Re:Goldman Sachs questions whether curing patients is a sust...
by ransom1538 on Friday April 13, 2018 @06:38AM
(#16828647)
Also* this 'ideal' drug has a difficult time being covered by healthcare. At all possible this drug should not cure the patient, be taken for a lifetime, not be healthcare covered [if possible], needed daily, easily marketable, be IP protected [for as long as possible] AND have the ability to survive even with generics on the market : viagra, propecia, etc.
[ Parent
| on HN ]
There are no comments on this comment yet.